Navigation Links
Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals
Date:5/8/2008

come encoded with IL-12 and function as "miniature factories" producing the IL-12 protein at very high levels in the tumor site, according to the study.

Additionally, the serious side effects previously documented with systemic use of IL-12 were not found in the treated rats. The liver, lung and spleen remained normal throughout the study. The delivery technique through free flaps did not cause liver toxicity, whereas using IL-12 intravenously in humans has been shown to cause liver damage.

"This could be a major advance for the delivery of a therapeutic agent to diseased parts of the body," said Dr. Gurtner. "I can see this therapy being used for breast cancer, head and neck cancers, central nervous system malignancies, and somewhere down the line hemophilia, diabetes and infections."

The study authors concluded that as oncologic reconstructive surgery is a major component of plastic surgery, the delivery of a healing agent precisely to the region where cancer was and where local recurrences are most likely to occur, could add a new dimension to the reconstructive function of free flaps in oncologic and reconstructive plastic surgery.

Nearly 5.2 million reconstructive plastic surgery procedures were performed in 2007, according to ASPS statistics. More than 3.8 million tumor removals and 57,000 breast reconstructions were performed last year.

Visit http://www.plasticsurgery.org for referrals to ASPS Member Surgeons and to learn more about cosmetic and reconstructive plastic surgery.

The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. Representing more than 6,700 physician members, the Society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 90 percent of all board-certified plastic surgeons in the United
'/>"/>

SOURCE American Society of Plastic Surgeons
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
2. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
3. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
4. Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice
5. Researchers Train the Immune System to Deliver Virus That Destroys Cancer in Lab Models
6. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
7. Study Shows Intradigms RNAi Nanoplex Technology To Be Effective Systemic siRNA Delivery Platform for the Treatment of Various Cancer Models
8. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
9. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
10. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
11. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...SAN DIEGO, May 9 /- Ardea B...ed on the discovery and development of,small- mole... and,inflammatory diseases, including gout, today ...ior Vice President, Finance and Operations and Chi...ll resign from our board of,directors shortly ther...
(Date:5/9/2008)...Fifth International Phase III Study Shows Positive... Data -, NUTLEY, N.J., May 9 /- Roc...-year Phase III study showing that ACTEMRA(TM),(to...f structural damage to,joints in patients with rhe...ctiveness of an RA treatment. The study also demon...
(Date:5/8/2008)...CLEVELAND, May 8 /- DATATRA...gy and services company focused on global,eClinica...y reported its,operating results for the first qua...1, 2008, revenue decreased,approximately 41% to $2...2,233,000), or $(0.16) per share on both a basic a...
(Date:5/8/2008)...BOSTON, May 8 /- The Cancer Research ...ation,s top cancer centers, is asking,303 million ...onating $1 to,cancer research efforts this Mother,... the "Infinite Power of One(TM)" has two key goals... into their own hands by,joining together to exerc...
Breaking Medicine Technology:Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Tobacco marketers targeting teens near schools 7022 1Tobacco marketers targeting teens near schools 7022 2Combo PET CT Scan Helps Spot Breast Cancers Spread 7019 1Combo PET CT Scan Helps Spot Breast Cancers Spread 7019 2Combo PET CT Scan Helps Spot Breast Cancers Spread 7019 3Nastech to Present at BMO Capital Markets Focus on Healthcare Conference 1967 1Studies suggest HIV subtype more deadly than others 7015 1Studies suggest HIV subtype more deadly than others 7015 2
...le and Excellent,Pharmacokinetic Properties -, RES...ire/ --,CeNeRx BioPharma, Inc., a clinical stage c...reatments for diseases of the central,nervous syst...I,clinical trial of Tyrima(TM), its lead candidate...his study, Tyrima was safe and well,tolerated. Tyr...
...rstCall/ - Oncolytics,Biotech Inc. announced today...reovirus in combination with gemcitabine is availa...esearch (AACR),website at <a target="_blank" href=...Oncolytics,website at <a target="_blank" href=,"ht...tech.com .,The abstract is entitled "In Vivo Syner...
Other Medicine Technology:CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3Oncolytics Biotech Inc. Collaborators to Present,Reovirus/Gemcitabine Combination Research at AACR Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present,Reovirus/Gemcitabine Combination Research at AACR Annual Meeting 3
(Date:5/13/2008)...njecting healthy gene into brain slowed Batten dis...) -- A new gene therapy that involves injecting a ...afe and effective way to slow Batten disease, a ra...l between the ages of 8 and 12. , Children with...l Ceroid Lipofuscinosis, are born with a mutated C...
(Date:5/13/2008)...re/ -- It was a sellout for Actifirm(R), a,leading...ural botanicals,in its first hour-long show on QV...ett and Actifirm president Elysiann Bishop,present... Face Firm(TM);,Renovation Cream; Renovation Eye C...very kit with Actifirm products for cleansing, exf...
(Date:5/13/2008)...May 13 /PRNewswire/ -- Stater Bros. is pleased,to ...yees recently raised,$501,707 to benefit the Ameri...om.com/cgi-bin/prnh/20080513/LATU098 ), (Logo: h...LOGO ), Since 2002, Stater Bros. has raised over ...uring the month of February 2008, Stater Bros. cus...
(Date:5/13/2008)...32 Nurses Negotiating With Genesys Regional,Medica...wswire/ -- Teamsters General,President Jim Hoffa a...,Wednesday, May 14, 2008, to show community suppor... negotiations with Genesys Regional Medical,Center...e-to-patient ratios and to,continue quality, affor...
Breaking Medicine News(10 mins):Health News:Therapy Yields Promise for Fatal Neurological Condition 2Health News:Actifirm Sells Out in First Hour Appearance on QVC 2Health News:Stater Bros. Raises $501,707 for American Heart Association 2
...used for lowering cholesterol have been found to b...at the anti-cholesterol statin drugs are helpful i...thereby reducing the risk of diabetic retinopathy ...ing to foodconsumer.org, the Japanese study includ...
...ug, Chantix, which will help cigarette smokers to ...on’s approval//. The active ingredient in Chantix ...rity review based on the better effectiveness show...nother anti-smoking drug known as zyban. Drugs rec...
... addiction has reached alarming proportions, with ...s of other stimulant drugs such as heroin or cocai...that if appropriate steps are not taken to change ...eat. Methamphetamine or crystal meth, as it is co...
...tudent who had been bitten by a bat and subsequent...spital for further management// and observation. A... the boy recovering is very minimal, say the treat...le High School fell ill last week, unaware of the ...
Other Medicine News:Health News:Meth Addiction On The Rise, US Health Authorities Concerned 2
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: